Masivet tablets for dogs

Masivet tablets for dogs

Masivet tablets for dogs

PRESCRIPTION NEEDED (Pom-V)

Masivet tablets for dogs are prescribed for the treatment of specific mast cell tumours. These are a type of skin cancer.

Your vet will confirm whether your dog’s tumour fits the licensed use for Masivet. Blood tests, imaging and sometimes biopsy results are used before starting treatment.

Masivet tablets for dogs form part of a wider cancer care plan. This may include surgery, supportive care and regular monitoring.

When Masivet Tablets for Dogs Are Used

Vets may use Masivet tablets for dogs when:

• The mast cell tumour meets the product’s criteria

• Surgery alone is not enough or not possible

• Ongoing medical management has been advised

Masivet is not suitable for every dog with a mast cell tumour. Careful assessment is vital. Your vet will discuss all options and decide if Masivet is appropriate.

How Masivet Tablets for Dogs Work

Masivet tablets for dogs contain masitinib. Masitinib is a tyrosine kinase inhibitor.

It works by blocking certain signals in cancer cells. These signals help mast cell tumour cells grow and survive. By blocking them, Masivet tablets for dogs can slow or reduce tumour activity in some cases.

Your vet will explain what response they hope to see and how long treatment may continue.

Benefits of Masivet Tablets for Dogs

When used in suitable cases and under close veterinary supervision, Masivet tablets for dogs can:

• Help control eligible mast cell tumours

• Support longer-term management in some patients

• Form part of a structured oncology plan

• Be given at home once your dog is stable on treatment

Results vary between dogs. Regular reviews help your vet judge benefit and adjust the plan.

How to Give Masivet Tablets for Dogs

Always follow your vet’s instructions and the package leaflet. General guidance:

• Give the exact number of Masivet tablets for dogs prescribed

• Your vet will advise if tablets should be given with food

• Try to dose at the same time each day

• Do not crush or break tablets unless your vet specifically allows it

• Make sure your dog swallows the full tablet

Never alter the dose or stop treatment without speaking to your vet. If you miss a dose, or are unsure whether your dog received it, contact your vet for advice before giving more.

Monitoring and Follow-Up

Dogs on Masivet tablets for dogs need regular checks. Your vet may:

• Perform blood tests at set intervals

• Check kidney and liver function

• Examine your dog and assess the tumour

• Adjust the dose if side effects appear

You should contact your vet promptly if you notice:

• Vomiting or diarrhoea

• Loss of appetite or weight loss

• Lethargy or weakness

• Pale gums or any unusual bruising

• Any other sudden change that worries you

Keeping a simple diary of appetite, energy and stool quality can help your vet review treatment.

Safety Information

Masivet tablets for dogs are a POM-V oncology medicine. They must only be used under the close supervision of a veterinary surgeon and only for the dog named on the prescription.

Important points:

• Do not use Masivet tablets for dogs in other pets or in people

• Tell your vet about all other medicines or supplements your dog receives

• Inform your vet if your dog has liver, kidney, stomach or blood problems

• Pregnant or breastfeeding people should avoid handling the tablets or dog waste

If your vet has allowed you to split tablets, follow their handling advice carefully. Wash your hands after giving Masivet tablets for dogs. Clear up urine, faeces and vomit promptly and dispose of them safely.

Storage and Handling

• Keep Masivet tablets for dogs in the original blister and carton

• Store as directed on the pack, away from moisture and heat

• Keep out of sight and reach of children and animals

• Do not use after the expiry date on the packaging

Return any unused or expired Masivet tablets for dogs to your vet or pharmacist for safe disposal.

Used exactly as your vet directs, Masivet tablets for dogs can form an important part of the treatment plan for selected mast cell tumours, with the aim of supporting quality of life and careful, monitored cancer care.

You can download the data sheet here

You can visit the manufacturer’s website here

Available in 50mg, & 150mg – 30 Tablet Boxes